NCT06369389View on ClinicalTrials.gov

Real-life Management of Patients Eligible for CAR-T Cell Therapy

RecruitingOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

December 31, 2033

Study Completion Date

December 31, 2034

Conditions
Hemopathy
Interventions
OTHER

Patients eligible for CAR-T treatment

Patients eligible for CAR-T treatment for their hemopathy at TOULOUSE University Hospital under early access or marketing authorization or as part of a clinical trial between 01/01/2019 and 31/12/2028

Trial Locations (1)

31059

RECRUITING

CHU de Toulouse, Toulouse

All Listed Sponsors
collaborator

Ligue contre le cancer, France

OTHER

collaborator

Janssen, LP

INDUSTRY

lead

University Hospital, Toulouse

OTHER